Michael S Wyzga - Net Worth and Insider Trading
Michael S Wyzga Net Worth
The estimated net worth of Michael S Wyzga is at least $196,729 dollars as of 2024-05-27. Michael S Wyzga is the Director of Exact Sciences Corp and owns about 2,558 shares of Exact Sciences Corp (EXAS) stock worth over $127,491. Michael S Wyzga is also the Director of X4 Pharmaceuticals Inc and owns about 76,667 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $69,238. Details can be seen in Michael S Wyzga's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael S Wyzga has not made any transactions after 2023-08-18 and currently still holds the listed stock(s).
Transaction Summary of Michael S Wyzga
Michael S Wyzga Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Wyzga owns 7 companies in total, including Exact Sciences Corp (EXAS) , LogicBio Therapeutics Inc (LOGC) , and X4 Pharmaceuticals Inc (XFOR) among others .
Click here to see the complete history of Michael S Wyzga’s form 4 insider trades.
Insider Ownership Summary of Michael S Wyzga
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EXAS | Exact Sciences Corp | 2021-02-26 | director |
| LOGC | LogicBio Therapeutics Inc | 2018-10-18 | director |
| XFOR | X4 Pharmaceuticals Inc | 2023-08-18 | director |
 | | 2018-06-22 | director |
| | 2014-03-19 | director |
| | 2011-12-05 | director & Chief Executive Officer |
| | 2022-06-22 | director |
Michael S Wyzga Latest Holdings Summary
Michael S Wyzga currently owns a total of 2 stocks. Among these stocks, Michael S Wyzga owns 2,558 shares of Exact Sciences Corp (EXAS) as of February 26, 2021, with a value of $127,491 and a weighting of 64.81%. Michael S Wyzga also owns 76,667 shares of X4 Pharmaceuticals Inc (XFOR) as of August 18, 2023, with a value of $69,238 and a weighting of 35.19%.
Latest Holdings of Michael S Wyzga
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EXAS | Exact Sciences Corp | 2021-02-26 | 2,558 | 49.84 | 127,491 |
| XFOR | X4 Pharmaceuticals Inc | 2023-08-18 | 76,667 | 0.90 | 69,238 |
Holding Weightings of Michael S Wyzga
Michael S Wyzga Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Wyzga has made a total of 2 transactions in Exact Sciences Corp (EXAS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Exact Sciences Corp is the sale of 19,021 shares on February 26, 2021, which brought Michael S Wyzga around $2 Million.
According to the SEC Form 4 filings, Michael S Wyzga has made a total of 1 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 25,000 shares on August 18, 2023, which cost Michael S Wyzga around $30,000.
Insider Trading History of Michael S Wyzga
- 1
Michael S Wyzga Trading Performance
GuruFocus tracks the stock performance after each of Michael S Wyzga's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Wyzga is -31.35%. GuruFocus also compares Michael S Wyzga's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Wyzga within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael S Wyzga's insider trading performs compared to the benchmark.
Performance of Michael S Wyzga
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.03 | | | | | |
| Relative Return to S&P 500(%) | -7.95 | | | | | |
Michael S Wyzga Ownership Network
Michael S Wyzga Owned Company Details
What does Exact Sciences Corp do?
Who are the key executives at Exact Sciences Corp?
Michael S Wyzga is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include General Counsel James Herriott , Gen. Mgr. & Precision Oncology Brian Baranick , and director & Vice President Kevin T Conroy .
Exact Sciences Corp (EXAS) Insider Trades Summary
Over the past 18 months, Michael S Wyzga made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 36,358 shares made by Sarah Condella , a net sale of 7,501 shares made by James Herriott , and a net sale of 81,344 shares made by Kevin T Conroy .
In summary, during the past 3 months, insiders sold 33,920 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 33,920 shares. During the past 18 months, 242,269 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 242,269 shares.
Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exact Sciences Corp Insider Transactions
Michael S Wyzga Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Wyzga. You might contact Michael S Wyzga via mailing address: Radius Health, Inc., 201 Broadway, 6th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
